295 related articles for article (PubMed ID: 31987673)
21. HPV testing versus p16 immunohistochemistry in oropharyngeal squamous cell carcinoma: results from the DAHANCA 19 study.
Lilja-Fischer JK; Kristensen MH; Lassen P; Steiniche T; Tramm T; Stougaard M; Maare C; Johansen J; Primdahl H; Kristensen CA; Andersen M; Eriksen JG; Overgaard J
Acta Oncol; 2023 Nov; 62(11):1384-1388. PubMed ID: 37837201
[TBL] [Abstract][Full Text] [Related]
22. Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.
Nopmaneepaisarn T; Tangjaturonrasme N; Rawangban W; Vinayanuwattikun C; Keelawat S; Bychkov A
BMC Cancer; 2019 Nov; 19(1):1050. PubMed ID: 31694600
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice.
Thavaraj S; Stokes A; Guerra E; Bible J; Halligan E; Long A; Okpokam A; Sloan P; Odell E; Robinson M
J Clin Pathol; 2011 Apr; 64(4):308-12. PubMed ID: 21345874
[TBL] [Abstract][Full Text] [Related]
24. Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma--an in vivo and in vitro study.
Jouhi L; Datta N; Renkonen S; Atula T; Mäkitie A; Haglund C; Ahmed A; Syrjänen S; Grénman R; Auvinen E; Lehtonen S; Hagström J
Tumour Biol; 2015 Sep; 36(10):7755-64. PubMed ID: 25941114
[TBL] [Abstract][Full Text] [Related]
25. Inclusion of an E7 DNA Amplification Test Improves the Robustness of Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma Diagnosis.
Perera PY; Perera LP; Filkoski L; Chen W; Lichy JH; Paal E; Maxwell JH
World J Oncol; 2020 Feb; 11(1):1-8. PubMed ID: 32095184
[TBL] [Abstract][Full Text] [Related]
26. Histologic Typing in Oropharyngeal Squamous Cell Carcinoma: A 4-Year Prospective Practice Study With p16 and High-Risk HPV mRNA Testing Correlation.
Gondim DD; Haynes W; Wang X; Chernock RD; El-Mofty SK; Lewis JS
Am J Surg Pathol; 2016 Aug; 40(8):1117-24. PubMed ID: 27035614
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
[TBL] [Abstract][Full Text] [Related]
28. Utility of the Roche Cobas 4800 for detection of high-risk human papillomavirus in formalin-fixed paraffin-embedded oropharyngeal squamous cell carcinoma.
Pettus JR; Wilson TL; Steinmetz HB; Lefferts JA; Tafe LJ
Exp Mol Pathol; 2017 Feb; 102(1):47-49. PubMed ID: 27939577
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus (HPV) load is higher in HPVDNA/p16 positive than in HPVDNA positive/p16 negative oropharyngeal squamous cell carcinoma but does not differ significantly between various subsites or correlate to survival.
Zupancic M; Kostopoulou ON; Holzhauser S; Lukoseviciute M; Jylhä C; Marklund L; Näsman A; Sivars L; Dalianis T
Oral Oncol; 2024 Apr; 151():106749. PubMed ID: 38461771
[TBL] [Abstract][Full Text] [Related]
31. Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.
Biron VL; Kostiuk M; Isaac A; Puttagunta L; O'Connell DA; Harris J; Côté DW; Seikaly H
Cancer; 2016 May; 122(10):1544-51. PubMed ID: 26989832
[TBL] [Abstract][Full Text] [Related]
32. Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population.
Wang Z; Xia RH; Ye DX; Li J
PLoS One; 2016; 11(10):e0164491. PubMed ID: 27749915
[TBL] [Abstract][Full Text] [Related]
33. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
[TBL] [Abstract][Full Text] [Related]
34. HPV-related Oropharyngeal Squamous Cell Carcinoma: p16INK4A Immunohistochemistry or HPV Genotyping?
Orsaria M; Marzinotto S; De Marchi L; Giacomarra V; Boria S; Rubini C; Londero AP; Di Loreto C; Mariuzzi L
Anticancer Res; 2015 Sep; 35(9):4733-9. PubMed ID: 26254363
[TBL] [Abstract][Full Text] [Related]
35. Identification of transcriptionally active HPV infection in formalin-fixed, paraffin-embedded biopsies of oropharyngeal carcinoma.
Morbini P; Alberizzi P; Tinelli C; Paglino C; Bertino G; Comoli P; Pedrazzoli P; Benazzo M
Hum Pathol; 2015 May; 46(5):681-9. PubMed ID: 25708613
[TBL] [Abstract][Full Text] [Related]
36. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
[TBL] [Abstract][Full Text] [Related]
37. Human papillomavirus and oral and oropharyngeal carcinoma: the essentials.
Yakin M; Seo B; Hussaini H; Rich A; Hunter K
Aust Dent J; 2019 Mar; 64(1):11-18. PubMed ID: 30238467
[TBL] [Abstract][Full Text] [Related]
38. A clinical analysis of oropharyngeal squamous cell carcinoma: a single-institution's experience.
Jiromaru R; Yasumatsu R; Yamamoto H; Kuga R; Hongo T; Nakano T; Manako T; Hashimoto K; Wakasaki T; Matsuo M; Nakagawa T
Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3717-3725. PubMed ID: 34978590
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus in oropharyngeal squamous cell carcinoma: assessing virus presence in normal tissue and activity in cervical metastasis.
Laborde RR; Janus JR; Olsen SM; Wang VW; Garcia JJ; Graham RP; Moore EJ; Olsen KD; Kasperbauer JL; Price DL; Berres M; Halling G; Smith DI
Laryngoscope; 2012 Dec; 122(12):2707-11. PubMed ID: 22961429
[TBL] [Abstract][Full Text] [Related]
40. Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes.
Arsa L; Siripoon T; Trachu N; Foyhirun S; Pangpunyakulchai D; Sanpapant S; Jinawath N; Pattaranutaporn P; Jinawath A; Ngamphaiboon N
BMC Cancer; 2021 May; 21(1):504. PubMed ID: 33957888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
